期刊文献+

耐碳青霉烯肺炎克雷伯菌的耐药机制及流行特征研究 被引量:2

下载PDF
导出
摘要 目的 研究医院耐碳青霉烯类抗生素耐药肺炎克雷伯菌的耐药机制和分子同源性,为医院感染的预防和控制提供可靠的研究基础.方法 收集临床分离的碳青霉烯类抗生素耐药肺炎克雷伯菌;琼脂稀释法测定抗生素最低抑菌浓度(MIC);PCR特异扩增和序列比对分析研究细菌对碳青霉烯类抗生素耐药的分子机制及流行特征.结果 分离碳青霉烯类抗生素耐药的肺炎克雷伯菌共189株,均为产blaKPC-2肺炎克雷伯菌,其对美罗培南、亚胺培南和厄他培南的MIC范围分别为2~128mg/L、4~128mg/L、4~128mg/L.其中5株细菌同时产blaVIM-1.ERIC分型显示189株细菌分为a型、b型,其中a型较多(67.9%).结论 院内可能有过携带blaKPC-2的肺炎克雷伯菌引起的医院内暴发流行,需要加强消毒隔离,防止进一步播散. Objective To investigate the mechanism of reduced susceptibility to carbapenems of Klebsiella pneumoniae and its homology.Methods The clinical isolates of carbapenem-resistant Klebsiella pneumoniae were collected,The minimum inhibitory concentration(MIC)of antibiotics was determined by agar dilution method.The molecular mechanism and epidemiological characteristics of carbapenem-resistant bacteria were analyzed by PCR-specific amplification and sequence alignment.Results A total of 64 carbapenem-resistant Klebsiella pneumoniae strains were isolated.All of them were BlaKPC-2-producing Klebsiella pneumoniae.The MIC ranges of meropenem,imipenem and ertapenem were 2~128mg/L,4~128mg/L,4~128mg/L,respectively.2 strains of bacteria produce blaVIM-1 simultaneously.ERIC typing showed that 64 strains of bacteria were classified into type A and B,among which type A was more(67.9%).Conclusion Hospital outbreaks caused by Klebsiella pneumoniae carrying blaKPC-2 may have occurred in hospitals,and disinfection and isolation should be strengthened to prevent further dissemination.
出处 《浙江临床医学》 2019年第6期750-751,754,共3页 Zhejiang Clinical Medical Journal
关键词 肺炎克雷伯菌 碳青霉烯 KPC-2 Klebsiella pneumoniae Carbapenem KPC-2
  • 相关文献

参考文献3

二级参考文献67

  • 1季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172
  • 2宦定才.金属β-内酰胺酶及抑制剂研究进展[J].中国医刊,2006,41(10):26-27. 被引量:2
  • 3Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem- hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother, 2001,45:1151-1161.
  • 4Smith Moland E, Hanson ND, Herrera VL, et al. Plasmid- mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother, 2003, 51 : 711-714.
  • 5Miriagou V, Tzouvelekis LS, Rossiter S, et al. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chernother, 2003, 47 : 1297-1300.
  • 6Yigit H, Queenan AM, Rasheed JK, et al. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrob Agents Chemother, 2003,47 : 3881-3889.
  • 7Hossain A, Ferraro MJ, Pino RM, et al. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob Agents Chemother, 2004, 48: 4438-4440.
  • 8Woodford N, Tiemo PM Jr, Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother, 2004, 48: 4793-4799.
  • 9Bratu S, Landman D, Alam M, et al. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother, 2005, 49: 776-778.
  • 10Naas T, Nordmann P, Vedel G, et al. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a KlebsieUa pneumoniae isolate from France. Antimicrob Agents Chemother, 2005, 49 : 4423-4424.

共引文献48

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部